Ultragenyx, NephroGenex set IPO terms

Orphan drug company Ultragenyx Pharmaceutical Inc. (Novato, Calif.) and kidney disease company NephroGenex Inc. (Research Triangle Park, N.C.) set IPO terms late

Read the full 227 word article

User Sign In